Diadema Partners LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Diadema Partners LP disclosed 54 US equity positions worth $88.7m in its Q4 2024 13F filing. The largest position was BMY at 10.2% of the reported book, followed by ABBV and TEVA.
What did Diadema Partners LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 10.2% | $9.0m | 160,000 | – | |
| 2 | ABBV ABBVIE INC | Healthcare | 10.0% | $8.9m | 50,000 | – | |
| 3 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.5% | $6.7m | 300,000 | – | |
| 4 | 2655787D BLUEPRINT MEDICINES CORP | 6.3% | $5.6m | 64,193 | – | ||
| 5 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 4.7% | $4.2m | 75,000 | – | |
| 6 | AZN ASTRAZENECA PLC | Healthcare | 4.4% | $3.9m | 30,000 | – | |
| 7 | INSM INSMED INC | Healthcare | 4.4% | $3.9m | 56,337 | – | |
| 8 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.9% | $3.5m | 25,276 | – | |
| 9 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 3.7% | $3.3m | 60,000 | – | |
| 10 | SLNOEUR SOLENO THERAPEUTICS INC | 3.6% | $3.2m | 71,988 | – | ||
| 11 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.8% | $2.5m | 165,965 | – | |
| 12 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.6% | $2.3m | 53,160 | – | |
| 13 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.6% | $2.3m | 50,620 | – | |
| 14 | CNTA CENTESSA PHARMACEUTICALS PLC | 2.5% | $2.2m | 131,862 | – | ||
| 15 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.3% | $2.1m | 505,778 | – | |
| 16 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 2.0% | $1.8m | 14,719 | – | |
| 17 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.9% | $1.7m | 214,291 | – | |
| 18 | TGTX TG THERAPEUTICS INC | Healthcare | 1.6% | $1.4m | 47,805 | – | |
| 19 | REPL REPLIMUNE GROUP INC | Healthcare | 1.6% | $1.4m | 114,000 | – | |
| 20 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.5% | $1.3m | 25,900 | – | ||
| 21 | VTGN VISTAGEN THERAPEUTICS INC | 1.5% | $1.3m | 442,520 | – | ||
| 22 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.4% | $1.2m | 60,000 | – | |
| 23 | NUVALENT INC | 1.3% | $1.2m | 14,701 | – | ||
| 24 | EOLS EVOLUS INC | Healthcare | 1.2% | $1.1m | 97,423 | – | |
| 25 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.1% | $1.0m | 63,547 | – | |
| 26 | BNTX BIONTECH SE | Healthcare | 1.1% | $999.0k | 8,767 | – | |
| 27 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.1% | $948.5k | 49,478 | – | |
| 28 | PCVX VAXCYTE INC | Healthcare | 0.9% | $818.6k | 10,000 | – | |
| 29 | ACLXGBX ARCELLX INC | 0.9% | $774.6k | 10,100 | – | ||
| 30 | GHRS GH RESEARCH PLC | 0.8% | $710.5k | 101,502 | – | ||
| 31 | GERN GERON CORP | Healthcare | 0.8% | $708.0k | 200,000 | – | |
| 32 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.8% | $702.0k | 90,000 | – | |
| 33 | CLYM CLIMB BIO INC | 0.8% | $674.0k | 374,423 | – | ||
| 34 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.7% | $650.0k | 698,919 | – | |
| 35 | URGN UROGEN PHARMA LTD | Healthcare | 0.6% | $532.5k | 50,000 | – | |
| 36 | ALEC ALECTOR INC | Healthcare | 0.5% | $451.7k | 239,019 | – | |
| 37 | ARGX ARGENX SE | Healthcare | 0.5% | $422.0k | 679 | – | |
| 38 | ONC BEIGENE LTD | Healthcare | 0.5% | $421.7k | 30,000 | – | |
| 39 | PROQR THRAPEUTICS N V | 0.5% | $418.8k | 158,023 | – | ||
| 40 | ERAS ERASCA INC | Healthcare | 0.4% | $394.0k | 156,973 | – | |
| 41 | ZVRA ZEVRA THERAPEUTICS INC | 0.4% | $351.0k | 42,081 | – | ||
| 42 | ALXO ALX ONCOLOGY HLDGS INC | Healthcare | 0.4% | $330.1k | 197,680 | – | |
| 43 | ELDN ELEDON PHARMACEUTICALS INC | 0.4% | $312.3k | 75,794 | – | ||
| 44 | 430 TERNS PHARMACEUTICALS INC | 0.3% | $279.1k | 50,370 | – | ||
| 45 | GOSS GOSSAMER BIO INC | Healthcare | 0.2% | $197.2k | 217,987 | – | |
| 46 | CADL CANDEL THERAPEUTICS INC | 0.2% | $173.6k | 20,000 | – | ||
| 47 | SABS SAB BIOTHERAPEUTICS INC | 0.1% | $113.8k | 30,000 | – | ||
| 48 | CMRXEUR CHIMERIX INC | 0.1% | $101.2k | 29,082 | – | ||
| 49 | QTTB Q32 BIO INC | 0.1% | $67.8k | 19,700 | – | ||
| 50 | EWTX EDGEWISE THERAPEUTICS INC | 0.0% | $36.3k | 1,359 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.